The sight test fee Effectiveness for treatment for glaucoma remains unprovedBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6965.1369b (Published 19 November 1994) Cite this as: BMJ 1994;309:1369
- L Clearkin
- Arrowe Park Hospital, Upton, Wirral, Merseyside L49 5PE
EDITOR, - D A H Laidlaw and colleagues are concerned that the prevalence of blindness due to glaucoma may increase because of reduced uptake of screening since the introduction of the sight test fee.1 Their implication is that treatment …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial